Resveratrol could enhance sirt1/AMPK expression to suppress ACC activity, increase β-oxidation for lipolysis, and improve NAFLD in HFD induced mice [8,40]. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.